LEGN Legend Biotech Corporation

LEGN Legend Biotech Corporation

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $18.45 · VWAP $23.48 · -21.3% vs 12m avg buyer

collapse vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster CFO, Director sold $308.6K, Sep 23–Oct 1

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

LEGN Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist LEGN belongs to, members best 30-day change first — LEGN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings LEGN reports in 25 days Nov 11

Last report Aug 11

Legend Biotech furnished its report for the period ended June 30, 2026 to the SEC on Form 6-K on August 11, 2026. No figures from this filing are recorded here.

full note →

Against street estimates

How LEGN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 11 · projection Oct 16

Result
Aug 11 0.280.32+14.3%Beat
Mar 10 0.19-0.16-184.4%Miss
Nov 12 '25 -0.18-0.22 GAAP ≠ -18.9%Miss
Aug 11 '25 -0.23-0.68 GAAP ≠ -195.7%Miss
May 13 '25 -0.34-0.54 GAAP ≠ -61.5%Miss
Mar 11 '25 -0.430.14+133.5%Beat
Nov 12 '24 -0.60-0.68 GAAP ≠ -12.8%Miss
Aug 9 '24 -0.42-0.10+76.0%Beat
Types
Aug 11 Catalyst LEGN earnings
May 12 Catalyst LEGN earnings
Mar 10 Article Daily Actions
Feb 11 Article Daily Actions